NASDAQ:TNXP
Tonix Pharmaceuticals Stock News
$0.171
-0.0059 (-3.33%)
At Close: May 02, 2024
Tonix Pharmaceuticals $70M; Plans To Develop COVID-19 Skin Test
01:15pm, Monday, 08'th Feb 2021
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has entered into a securities purchase agreement with institutional investors to purchase 58.3 million shares at $1.20 per share, raising gross pr
Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules
10:30am, Monday, 08'th Feb 2021
CHATHAM, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced i
TNXP Stock: Why Tonix Pharmaceuticals Shares Are on the Move Today
09:20am, Thursday, 04'th Feb 2021
TNXP stock is on the move today as investors speculate over potential patent approval and Tonix's drug candidate for Alzheimer's. The post TNXP Stock: Why Tonix Pharmaceuticals Shares Are on the Move
TNXP Stock Price Increases Over 30% Pre-Market: Why It Happened
05:23am, Thursday, 04'th Feb 2021
The stock price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is trading at over 30% pre-market today as of 5:06 AM ET. This is why it happened.
Tonix Pharmaceuticals CEO Believes That Additional COVID-19 Vaccine Research Is Still Needed
08:51am, Tuesday, 02'nd Feb 2021
Tonix Pharmaceuticals was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. The information contained in this article in no way represents investm
GMP Production of TNX-1500 is Expected to be Available in the Third Quarter of 2021
Tonix Pharmaceuticals Holdings Corp. Closes $40M Common Stock Offering Priced At-the-Market Under Nasdaq Rules
04:05pm, Wednesday, 13'th Jan 2021
CHATHAM, N.J., Jan. 13, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced th
Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock Offering Priced at-the-Market Under Nasdaq Rules
12:59pm, Monday, 11'th Jan 2021
CHATHAM, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced i
Tonix Pharmaceuticals to Participate in Upcoming January Conferences
04:15pm, Tuesday, 05'th Jan 2021
CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederm
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility
09:00am, Wednesday, 23'rd Dec 2020
Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19
University of Geneva Technology Covers Broad Applications for Cardiometabolic Syndromes University of Geneva Technology Covers Broad Applications for Cardiometabolic Syndromes
Tonix Pharmaceuticals News: TNXP Stock Soars on Fibromyalgia Drug Results
10:21am, Monday, 07'th Dec 2020
Tonix Pharmaceuticals (TNXP) news for Monday includes results from a recent Phase 3 clinical trial boosting TNXP stock higher. The post Tonix Pharmaceuticals News: TNXP Stock Soars on Fibromyalgia Dru
Covid-19 Is Not Going to Go Away: Tonix Pharmaceuticals CEO
12:30am, Monday, 07'th Dec 2020
Dec.06 -- Seth Lederman, chairman and chief executive officer of Tonix Pharmaceuticals, talks about the coronavirus outbreak and the rollout of vaccines. Tonix has two Covid-19 vaccine in the pipeline
Anti-SARS-CoV-2 Neutralizing Antibodies Elicited in All Eight TNX-1800 Vaccinated Animals
Increasing Placebo Responses in PTSD Drug Trials Raise Questions About Current Methods of Measuring or Analyzing PTSD Symptom Change Over Time
